With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half
As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic. GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources
To download a PDF version of this infographic, please click here.
Two weeks ago, on 17 March, as governments around the world began closing borders, a flight arrived at Sydney airport from the US. On board was the first consignment of thousands of new COVID-19 diagnostic testing kits that had been developed by Roche Diagnostics within weeks of the outbreak in Wuhan, China. Their arrival was
GP practices across Australia are rising to the challenge of COVID-19. By far, the most widely read Australian Doctor article this week is a Quick Guide to Medicare funding for telehealth consultations. A close second is a recent article that that discusses the impact of the pandemic on day-to-day practice. Other articles and reader comments
With news COVID-19 is now a pandemic, we understand businesses are, and will, face many challenges and increasing uncertainty in the coming weeks and months. At ADG, we are doing our best to keep GPs and the wider healthcare professional community up to date on this unprecedented and evolving issue. We are posting news as
Australian Doctor Group (ADG) has retained its No.1 spot in both digital and print GP reach and engagement, according to the latest Medical Publishers Association’s readership survey. The company’s newly released supersite, AusDoc.PLUS, delivered unrivalled GP engagement with 48.4% of GPs visiting the platform monthly, 20.1 percentage points clear of Australian Journal of General Practice,
The 15th annual PRIME Awards saw some of the best and the brightest in the pharmaceutical and media industries come together to celebrate their achievements in healthcare communications. Hard work, creativity and innovation paid off for a record number of finalists who walked the red carpet on Thursday night at Sydney’s Four Season’s Hotel. But
Australian Doctor Group, the country’s number one healthcare media company, is moving its monthly masthead Medical Observer to digital-only next month to meet growing online demand. The important milestone comes after rapid growth in popularity of the masthead’s digital offering following the launch of ADG’s new supersite AusDoc.PLUS five months ago. Since April, the number of doctors
As the lines between journalism and marketing continue to blur, it would be rare these days to find a content marketing agency without at least one journalist on the team. Journalists bring an editorial approach to building a brand. Here’s why that’s important:
A healthy pipeline feeds a changing treatment landscape A record number of oncology drugs was launched in 2018 with a global report recording 15 new cancer drugs for 17 indications last year. In fact, over the past five years oncology treatments appear to have taken centre stage for the pharmaceutical industry. Some 57 oncology therapies for 89
Leading healthcare media company Australian Doctor Group (ADG) announced today that its new digital sales channel, AccessPlus has “exceeded expectations” with 12 brands signed-on to the platform across a range of therapeutic areas, including respiratory, diabetes, weight loss, dermatology, smoking cessation, female sexual health, mental health, and oncology. Launched late last year, AccessPlus is a